|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Brugarolas J: Molecular genetics of
clear-cell renal cell carcinoma. J Clin Oncol. 32:1968–1976. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rossi SH, Klatte T, Usher-Smith J and
Stewart GD: Epidemiology and screening for renal cancer. World J
Urol. 36:1341–1353. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ljungberg B, Bensalah K, Canfield S,
Dabestani S, Hofmann F, Hora M, Kuczyk MA, Lam T, Marconi L,
Merseburger AS, et al: EAU guidelines on renal cell carcinoma: 2014
update. Eur Urol. 67:913–924. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Karbasforooshan H, Roohbakhsh A and Karimi
G: SIRT1 and microRNAs: The role in breast, lung and prostate
cancers. Exp Cell Res. 367:1–6. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kian R, Moradi S and Ghorbian S: Role of
components of microRNA machinery in carcinogenesis. Exp Oncol.
40:2–9. 2018.PubMed/NCBI
|
|
7
|
Fan Y, Ma X, Li H, Gao Y, Huang Q, Zhang
Y, Bao X, Du Q, Luo G, Liu K, et al: miR-122 promotes metastasis of
clear-cell renal cell carcinoma by downregulating Dicer. Int J
Cancer. 142:547–560. 2018. View Article : Google Scholar
|
|
8
|
Kabir TD, Ganda C, Brown RM, Beveridge DJ,
Richardson KL, Chaturvedi V, Candy P, Epis M, Wintle L, Kalinowski
F, et al: A microRNA-7/growth arrest specific 6/TYRO3 axis
regulates the growth and invasiveness of sorafenib-resistant cells
in human hepatocellular carcinoma. Hepatology. 67:216–231. 2018.
View Article : Google Scholar
|
|
9
|
Fang L, Deng Z, Shatseva T, Yang J, Peng
C, Du WW, Yee AJ, Ang LC, He C, Shan SW and Yang BB: MicroRNA
miR-93 promotes tumor growth and angiogenesis by targeting
integrin-β8. Oncogene. 30:806–821. 2011. View Article : Google Scholar
|
|
10
|
Jia YJ, Liu ZB, Wang WG, Sun CB, Wei P,
Yang YL, You MJ, Yu BH, Li XQ and Zhou XY: HDAC6 regulates
microRNA-27b that suppresses proliferation, promotes apoptosis and
target MET in diffuse large B-cell lymphoma. Leukemia. 32:703–711.
2018. View Article : Google Scholar
|
|
11
|
Ferreira AF, Calin GA, Picanco-Castro V,
Kashima S, Covas DT and de Castro FA: Hematopoietic stem cells from
induced pluripotent stem cells-considering the role of microRNA as
a cell differentiation regulator. J Cell Sci. 131:pii:
jcs2030182018. View Article : Google Scholar
|
|
12
|
Kim S, Lee E, Jung J, Lee JW, Kim HJ, Kim
J, Yoo HJ, Lee HJ, Chae SY, Jeon SM, et al: microRNA-155 positively
regulates glucose metabolism via PIK3R1-FOXO3a-cMYC axis in breast
cancer. Oncogene. 37:2982–2991. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hu W, Tan C, He Y, Zhang G, Xu Y and Tang
J: Functional miRNAs in breast cancer drug resistance. Onco Targets
Ther. 11:1529–1541. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hosseinahli N, Aghapour M, Duijf PHG and
Baradaran B: Treating cancer with microRNA replacement therapy: A
literature review. J Cell Physiol. 233:5574–5588. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bhat NS, Colden M, Dar AA, Saini S, Arora
P, Shahryari V, Yamamura S, Tanaka Y, Kato T, Majid S and Dahiya R:
MicroRNA-720 regulates E-cadherin-αE-catenin complex and promotes
renal cell carcinoma. Mol Cancer Ther. 16:2840–2848. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dasgupta P, Kulkarni P, Majid S, Shahryari
V, Hashimoto Y, Bhat NS, Shiina M, Deng G, Saini S, Tabatabai ZL,
et al: MicroRNA-203 inhibits long noncoding RNA HOTAIR and
regulates tumorigenesis through epithelial-to-mesenchymal
transition pathway in renal cell carcinoma. Mol Cancer Ther.
17:1061–1069. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Han Z, Zhang Y, Sun Y, Chen J, Chang C,
Wang X and Yeh S: ERβ-mediated alteration of circATP2B1 and
miR-204-3p signaling promotes invasion of clear cell renal cell
carcinoma. Cancer Res. 78:2550–2563. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang M, Sun Y, Xu J, Lu J, Wang K, Yang
DR, Yang G, Li G and Chang C: Preclinical studies using miR-32-5p
to suppress clear cell renal cell carcinoma metastasis via altering
the miR-32-5p/TR4/HGF/Met signaling. Int J Cancer. 143:100–112.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tan X, Tang H, Bi J, Li N and Jia Y:
MicroRNA-222-3p associated with Helicobacter pylori targets HIPK2
to promote cell proliferation, invasion, and inhibits apoptosis in
gastric cancer. J Cell Biochem. 119:5153–5162. 2018. View Article : Google Scholar
|
|
20
|
Li Q, Shen K, Zhao Y, He X, Ma C, Wang L,
Wang B, Liu J and Ma J: MicroRNA-222 promotes tumorigenesis via
targeting DKK2 and activating the Wnt/β-catenin signaling pathway.
FEBS Lett. 587:1742–1748. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yamashita R, Sato M, Kakumu T, Hase T,
Yogo N, Maruyama E, Sekido Y, Kondo M and Hasegawa Y: Growth
inhibitory effects of miR-221 and miR-222 in non-small cell lung
cancer cells. Cancer Med. 4:551–564. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
24
|
Barata PC and Rini BI: Treatment of renal
cell carcinoma: Current status and future directions. CA Cancer J
Clin. 67:507–524. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lightell DJ Jr, Moss SC and Woods TC:
Upregulation of miR-221 and -222 in response to increased
extracellular signal-regulated kinases 1/2 activity exacerbates
neointimal hyperplasia in diabetes mellitus. Atherosclerosis.
269:71–78. 2018. View Article : Google Scholar
|
|
26
|
Zhao X, Wang P, Liu J, Zheng J, Liu Y,
Chen J and Xue Y: Gas5 exerts tumor-suppressive functions in Human
Glioma cells by targeting miR-222. Mol Ther. 23:1899–1911. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gao H, Cong X, Zhou J and Guan M:
MicroRNA-222 influences migration and invasion through MIA3 in
colorectal cancer. Cancer Cell Int. 17:782017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang Y, Yao J, Huan L, Lian J, Bao C, Li
Y, Ge C, Li J, Yao M, Liang L and He X: GNAI3 inhibits tumor cell
migration and invasion and is post-transcriptionally regulated by
miR-222 in hepatocellular carcinoma. Cancer Lett. 356:978–984.
2015. View Article : Google Scholar
|
|
29
|
Lv S, Xue J, Wu C, Wang L, Wu J, Xu S,
Liang X and Lou J: Identification of A panel of serum microRNAs as
biomarkers for early detection of lung adenocarcinoma. J Cancer.
8:48–56. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lee C, He H, Jiang Y, Di Y, Yang F, Li J,
Jin C and Fu D: Elevated expression of tumor miR-222 in pancreatic
cancer is associated with Ki67 and poor prognosis. Med Oncol.
30:7002013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Han SH, Kim HJ, Gwak JM, Kim M, Chung YR
and Park SY: MicroRNA-222 expression as a predictive marker for
tumor progression in hormone receptor-positive breast cancer. J
Breast Cancer. 20:35–44. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Puerta-Gil P, Garcia-Baquero R, Jia AY,
Ocaña S, Alvarez-Múgica M, Alvarez-Ossorio JL, Cordon-Cardo C, Cava
F and Sánchez-Carbayo M: miR-143, miR-222, and miR-452 are useful
as tumor stratification and noninvasive diagnostic biomarkers for
bladder cancer. Am J Pathol. 180:1808–1815. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chang YA, Weng SL, Yang SF, Chou CH, Huang
WC, Tu SJ, Chang TH, Huang CN, Jong YJ and Huang HD: A
Three-MicroRNA signature as a potential biomarker for the early
detection of oral cancer. Int J Mol Sci. 19:pii: E7582018.
View Article : Google Scholar
|
|
34
|
Kafshdooz L, Pourfathi H, Akbarzadeh A,
Kafshdooz T, Razban Z, Sheervalilou R, Ebrahimi Sadr N, Khalilov R,
Saghfi S, Kavetskyy T, et al: The role of microRNAs and
nanoparticles in ovarian cancer: A review. Artif Cells Nanomed
Biotechnol. 1–7. 2018.Epub ahead of print. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Meo AD, Saleeb R, Wala SJ, Khella HW, Ding
Q, Zhai H, Krishan K, Krizova A, Gabril M, Evans A, et al: A
miRNA-based classification of renal cell carcinoma subtypes by PCR
and in situ hybridization. Oncotarget. 9:2092–2104. 2017.
|
|
36
|
Youssef YM, White NM, Grigull J, Krizova
A, Samy C, Mejia-Guerrero S, Evans A and Yousef GM: Accurate
molecular classification of kidney cancer subtypes using microRNA
signature. Eur Urol. 59:721–730. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Brodaczewska KK, Szczylik C, Fiedorowicz
M, Porta C and Czarnecka AM: Choosing the right cell line for renal
cell cancer research. Mol Cancer. 15:832016. View Article : Google Scholar : PubMed/NCBI
|
